Board Certification Exposure and Awareness Among United States Doctor of Pharmacy Programs
JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY · 2026-12 · 9 (12)
DOI: 10.1002/jac5.70320 ↗Kurz gefasst
Fachartikel in der Zeitschrift JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, online erschienen am 11.11.2026. Verfasst von Wesley D Kufel und 3 weiteren Autor:innen. Beteiligte Einrichtung: State University of New York Binghamton School of Pharmacy and Pharmaceutical Sciences, Binghamton, New York, USA. Hauptthemen laut MEDLINE: Certification, Education, Pharmacy, Graduate. Die Arbeit nennt 18 Literaturangaben. Gefördert von: Board of Pharmacy Specialties.
Abstract (Originalsprache)
Background
Board certification by the Board of Pharmacy Specialties (BPS) is increasingly recognized as a marker of advanced clinical pharmacy practice for clinical pharmacists providing direct patient care. While board certification exposure and awareness have been described in pharmacy residency programs, data are lacking regarding within Doctor of Pharmacy (Pharm.D.) curricula.
Methods
A national cross‐sectional survey was distributed to administrators involved in curriculum oversight or pharmacy practice department chairs at Pharm.D. programs at U.S. Colleges and Schools of Pharmacy (CSoP). The primary outcome was the percentage of CSoPs intentionally delivering board certification exposure within the Pharm.D. curriculum. Secondary outcomes included delivery methods, faculty perceptions regarding board certification, awareness of BPS student resources, and factors associated with curricular inclusion.
Results
The response rate was 71.0% (98/138). Overall, 41.8% (41/98) of programs intentionally delivered board certification exposure. Among programs providing exposure, required didactic coursework was the most common setting (82.9%), most devoted ≤ 1 h to this content (43.9%), and lecture was the predominant delivery method (82.9%). Only 24.5% of respondents were aware that BPS resources were available for pharmacy students. Carnegie Classification was significantly associated with curricular inclusion of board certification exposure (Cramer's V = 0.40; p = 0.010) with most being RCU (84.6%) than R1 (40.6%) or R2 (30.8%) CSoPs. Pharm.D. programs who include board certification exposure currently were more likely to indicate that board certification should be included within the curriculum (Cramer's V = 0.46; p = 0.001).
Conclusion
Fewer than half of responding U.S. CSoPs intentionally deliver board certification exposure within the Pharm.D. curriculum despite general support for its inclusion. Exposure typically requires minimal curricular time and is most often incorporated into required didactic courses. Increased awareness and utilization of available BPS student resources may represent an opportunity to enhance professional development and career readiness among pharmacy students.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- State University of New York Binghamton School of Pharmacy and Pharmaceutical Sciences, Binghamton, New York, USA.
- State University of New York Upstate Medical University, Syracuse, New York, USA.
- University of Rochester, Rochester, New York, USA.
- University of Kentucky Healthcare, Lexington, Kentucky, USA.
ORCID-Profile: Wesley D Kufel, Sarah A Spinler
Förderung
- Board of Pharmacy Specialties
Zitieren
APA
Kufel, W. D., Blaine, B. E., Govel, J. C., & Spinler, S. A. (2026). Board Certification Exposure and Awareness Among United States Doctor of Pharmacy Programs. JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, 9(12). https://doi.org/10.1002/jac5.70320
Vancouver
Kufel WD, Blaine BE, Govel JC, Spinler SA. Board Certification Exposure and Awareness Among United States Doctor of Pharmacy Programs. JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 2026;9(12). doi:10.1002/jac5.70320
BibTeX
@article{Kufel2026,
author = {Kufel, Wesley D and Blaine, Bruce E and Govel, Jacob C and Spinler, Sarah A},
title = {Board Certification Exposure and Awareness Among United States Doctor of Pharmacy Programs},
journal = {JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY},
year = {2026},
volume = {9},
number = {12},
doi = {10.1002/jac5.70320}
}
EUVIMED